KATHERINE NIESPODZINSKI: Open Payments
NPI 1538574595 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 11 payments from 6 companies in 2025. Trend: 2023 $254 · 2024 $73 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| GENZYME CORPORATION | 3 | $59 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: DUPIXENT, NUCALA, FASENRA, NEMLUVIO, Rhapsido.
Industry payments across NY — which companies pay providers there.
